Nemus Bioscience Inc (OTCMKTS:NMUS – Get Free Report) passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.80 and traded as low as $0.6833. Nemus Bioscience shares last traded at $0.70, with a volume of 194,116 shares trading hands.
Nemus Bioscience Trading Down 4.0%
The firm has a market cap of $91.04 million, a PE ratio of -7.55 and a beta of -0.04. The business has a 50 day moving average price of $0.80.
Nemus Bioscience Company Profile
Nemus Bioscience, Inc is an early‐stage biopharmaceutical company developing proprietary prodrug cannabinoid therapeutics for ophthalmic, dermatological and metabolic diseases. The company leverages synthetic derivatives of naturally occurring cannabinoids, designed to improve bioavailability, tissue targeting and therapeutic efficacy. Nemus operates under an OTCMKTS listing and is headquartered in Houston, Texas.
The company’s pipeline includes multiple preclinical candidates, with lead programs focusing on ophthalmic and dermatological indications.
Featured Stories
- Five stocks we like better than Nemus Bioscience
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Receive News & Ratings for Nemus Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nemus Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
